Journal of Clinical Immunology and Allergy

Contamination Prevention

European Congress on Vaccines & Vaccination and Gynecologic Oncology
October 26-27 ,2018 Budapest , Hungary

Brian G Hubka

Contamination Prevention Technologies, USA

ScientificTracks Abstracts: Journal of Clinical Immunology and Allergy

DOI: 10.21767/2471-304X-C2-005

Abstract

Contamination Prevention is a common occurrence costing time delays for product release, product rejection by quality and product recall by the FDA. There are several new technologies that can quickly and completely eliminate contamination: • How to prevent certain types of contamination • Identify extremely effective disinfectants that don’t harm stainless steel • Identify easier methods to validate cleaning and disinfection using biological indicators • Preventing and eliminating biofilm with ambient water. Prevention, Effective, Easy, Biofilm

Biography

Brian G. Hubka is the CEO of Contamination Prevention Technologies, Inc. This company provides a vast array of contamination remediation and prevention technologies and products to eliminate and prevent mold, bacteria, viruses, prions and the like. They are also specialists in biofilm remediation and elimination. He also consults on contamination issues in pharmaceutical and biotechnology companies. Has worked with Pfizer, Amgen, Celgene and many others. He is a graduate of University of Notre Dame pre-medicine. He is also a frequent speaker and has authored book chapters for many PDA/DHI books.

E-mail: bhubka@contaminationprevention.com